Home » Topics » Regulatory

Regulatory
RSS

Roche's breakthrough flu treatment approved in Switzerland

Sep. 27, 1999

Acamprosate attenuates food craving in subjects with bulimia nervosa

Sep. 24, 1999

First treatment for postherpetic neuralgia reaches U.S. market

Sep. 24, 1999

Results of open-label study of topiramate in bipolar disorder justify additional trials

Sep. 23, 1999

Phase II study evaluating oral levalbuterol now under way in Canada

Sep. 23, 1999

Propofol is highly effective in treating refractory migraine pain

Sep. 21, 1999

FDA okays new pediatric formulation of zafirlukast

Sep. 21, 1999

ODAC recommends approval of another new indication for Taxol

Sep. 20, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Novo Nordisk's liquid growth hormone approved in the E.U.

Sep. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.